Researchers continue to excited about the medication , a novel dual treatment showing remarkable results in clinical trials for weight reduction . It acts by targeting both pathways : GLP-1 and GIP, https://jakubobhb150228.oblogation.com/39659261/a-new-possibility-for-weight-loss